CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-27 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 93,480 | ||
| 2021-08-26 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-08-26 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,895 | $33.89 | $132K | 69,360 |
| 2021-08-26 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 97,375 | ||
| 2021-08-25 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-08-25 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,895 | $34.09 | $133K | 69,360 |
| 2021-08-25 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 101,270 | ||
| 2021-08-16 | SOOD NITIN Chief Commercial Officer | Grant or award | +97,213 | 97,213 | ||
| 2021-08-16 | SOOD NITIN Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +162,022 | 162,022 | ||
| 2021-08-11 | Cohen Chad M Chief Financial Officer | Option exercise | +10,000 | $6.55 | $66K | 31,604 |
| 2021-08-11 | Cohen Chad M Chief Financial Officer | Sale | −8,738 | $33.48 | $293K | 22,866 |
| 2021-08-11 | Cohen Chad M Chief Financial Officer | Sale | −1,262 | $34.47 | $44K | 21,604 |
| 2021-08-11 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 75,000 | ||
| 2021-08-10 | Cohen Chad M Chief Financial Officer | Option exercise | +5,000 | $6.55 | $33K | 26,604 |
| 2021-08-10 | Cohen Chad M Chief Financial Officer | Sale | −5,000 | $35.00 | $175K | 21,604 |
| 2021-08-10 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 85,000 | ||
| 2021-07-21 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-07-21 | ROBINS HARLAN S Chief Scientific Officer | Sale | −1,400 | $37.29 | $52K | 71,855 |
| 2021-07-21 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,495 | $38.11 | $95K | 69,360 |
| 2021-07-21 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 105,165 |
Page 42 of 120 · 2,386 trades